Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESOMEPRAZOLE Cause Dermatitis bullous? 103 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Dermatitis bullous have been filed in association with ESOMEPRAZOLE (Esomeprazole Magnesium). This represents 0.1% of all adverse event reports for ESOMEPRAZOLE.

103
Reports of Dermatitis bullous with ESOMEPRAZOLE
0.1%
of all ESOMEPRAZOLE reports
9
Deaths
52
Hospitalizations

How Dangerous Is Dermatitis bullous From ESOMEPRAZOLE?

Of the 103 reports, 9 (8.7%) resulted in death, 52 (50.5%) required hospitalization, and 19 (18.4%) were considered life-threatening.

Is Dermatitis bullous Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE. However, 103 reports have been filed with the FAERS database.

What Other Side Effects Does ESOMEPRAZOLE Cause?

Chronic kidney disease (35,281) Acute kidney injury (18,678) Renal failure (14,633) End stage renal disease (10,231) Renal injury (9,440) Gastrooesophageal reflux disease (4,746) Drug ineffective (4,420) Tubulointerstitial nephritis (4,024) Off label use (3,180) Pain (2,898)

What Other Drugs Cause Dermatitis bullous?

LINAGLIPTIN (275) ACETAMINOPHEN (157) IBUPROFEN (142) FUROSEMIDE (140) PEMBROLIZUMAB (136) METHOTREXATE (129) VANCOMYCIN (115) CARBOPLATIN (105) NIVOLUMAB (103) AMOXICILLIN (100)

Which ESOMEPRAZOLE Alternatives Have Lower Dermatitis bullous Risk?

ESOMEPRAZOLE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE ESOMEPRAZOLE vs ESOMEPRAZOLE\NAPROXEN ESOMEPRAZOLE vs ESTAZOLAM ESOMEPRAZOLE vs ESTRADIOL ESOMEPRAZOLE vs ESTRADIOL CYPIONATE

Related Pages

ESOMEPRAZOLE Full Profile All Dermatitis bullous Reports All Drugs Causing Dermatitis bullous ESOMEPRAZOLE Demographics